Baxter Advate for hemophilia
Executive Summary
FDA clears Baxter's Advate clotting factor for patients with hemophilia A July 25. Advate is the first factor VIII product "produced without using additives derived from human or animal blood in the manufacturing process," an FDA "Talk Paper" says...